|
DNLZ expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.178500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.842210E-01 |
| Normal-vs-Stage2 |
1.109010E-01 |
| Normal-vs-Stage3 |
6.544100E-02 |
| Normal-vs-Stage4 |
1.459830E-02 |
| Stage1-vs-Stage2 |
4.574400E-01 |
| Stage1-vs-Stage3 |
5.816600E-01 |
| Stage1-vs-Stage4 |
1.233440E-01 |
| Stage2-vs-Stage3 |
6.644600E-01 |
| Stage2-vs-Stage4 |
6.037000E-01 |
| Stage3-vs-Stage4 |
2.709600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.610200E-02 |
| Normal-vs-AfricanAmerican |
1.016440E-04 |
| Normal-vs-Asian |
3.355600E-01 |
| Caucasian-vs-AfricanAmerican |
4.617600E-03 |
| Caucasian-vs-Asian |
4.342800E-01 |
| AfricanAmerican-vs-Asian |
4.078100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.920160E-02 |
| Normal-vs-Female |
6.608300E-02 |
| Male-vs-Female |
5.657600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.294400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.243500E-02 |
| Normal-vs-Age(61-80Yrs) |
4.780200E-02 |
| Normal-vs-Age(81-100Yrs) |
1.898230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.235200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.538400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.301800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.303200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.721400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.668200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.374000E-02 |
| Normal-vs-Grade 2 |
1.556760E-01 |
| Normal-vs-Grade 3 |
1.148250E-01 |
| Normal-vs-Grade 4 |
1.884370E-02 |
| Grade 1-vs-Grade 2 |
3.754000E-01 |
| Grade 1-vs-Grade 3 |
2.027200E-01 |
| Grade 1-vs-Grade 4 |
7.519600E-01 |
| Grade 2-vs-Grade 3 |
9.149000E-01 |
| Grade 2-vs-Grade 4 |
2.209600E-01 |
| Grade 3-vs-Grade 4 |
1.512240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.946200E-01 |
| Normal-vs-ccB subtype |
1.981200E-01 |
| ccA subtype-vs-ccB subtype |
6.985800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.566010E-01 |
| Normal-vs-N1 |
3.177800E-01 |
| N0-vs-N1 |
7.914800E-01 |
|
|
